Actively Recruiting

Phase Not Applicable
Age: 42Months - 78Months
All Genders
NCT06367192

School Readiness Intervention for Preschool Children With Sickle Cell Disease

Led by St. Jude Children's Research Hospital · Updated on 2026-04-24

36

Participants Needed

1

Research Sites

182 weeks

Total Duration

On this page

Sponsors

S

St. Jude Children's Research Hospital

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The study participant is being asked to take part in this clinical trial, a type of research study, because the participant is a young child with sickle cell disease or the caregiver of a child with sickle cell disease. This study is being done to test a school readiness program for children with sickle cell disease (ages 3.5-6,5 years old). Primary Objective Assess feasibility and acceptability of an adapted school readiness intervention among preschool children (ages 3.5-6.5) diagnosed with sickle cell disease. Secondary Objectives Objective 1: Measure preliminary efficacy of the adapted school readiness intervention compared to routine care among preschool children ages (3.5-6.5) diagnosed with sickle cell disease. Objective 2: Examine implementation factors (i.e., barriers and facilitators) during post-intervention.

CONDITIONS

Official Title

School Readiness Intervention for Preschool Children With Sickle Cell Disease

Who Can Participate

Age: 42Months - 78Months
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with sickle cell disease of any genotype
  • Enrolled in the institutional protocol: Sickle Cell Clinical Research Intervention Program (SCCRIP)
  • Aged 3.5 to 6.5 years inclusive at enrollment
  • English is the primary language
  • Research participant and one parent willing to participate and provide consent/assent
  • Caregiver has a child diagnosed with sickle cell disease aged 3.5 to 6.5 years enrolled in SCCRIP
  • English is the primary language for the caregiver
Not Eligible

You will not qualify if you...

  • Does not have a child diagnosed with sickle cell disease aged 3.5 to 6.5 years enrolled in SCCRIP
  • Non-English speakers

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

St. Jude Children's Research Hospital

Memphis, Tennessee, United States, 38105

Actively Recruiting

Loading map...

Research Team

A

ANDREW HEITZER, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here